Clinical trials
Phase 1 Idiopathic Pulmonary Fibrosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Not yet recruiting | 3 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overseas Pharmaceuticals, Ltd. | 3 |
| Sunshine Lake Pharma Co., Ltd. | 3 |
| Guangdong Hengrui Pharmaceutical Co., Ltd | 2 |
| Guangzhou JOYO Pharma Co., Ltd | 2 |
| Regend Therapeutics | 2 |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 1 |
| Huan Ye | 1 |
| Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
| Peking Union Medical College Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 20 |
| Pulmonary Fibrosis | 3 |
| Lung Diseases | 2 |
| Respiratory Tract Diseases | 2 |
| Idiopathic Interstitial Pneumonias | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.